Technical Analysis for PEPG - PepGen Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bullish Engulfing | Bullish | 0.00% | |
| Crossed Above 20 DMA | Bullish | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| 20 DMA Resistance | Bearish | 12.22% | |
| Volume Surge | Other | 12.22% | |
| Bollinger Band Squeeze | Range Contraction | 12.22% | |
| 20 DMA Resistance | Bearish | 8.81% | |
| Bollinger Band Squeeze | Range Contraction | 8.81% |
| Alert | Time |
|---|---|
| Up 10% | about 8 hours ago |
| Rose Above 20 DMA | about 8 hours ago |
| 60 Minute Opening Range Breakout | about 8 hours ago |
| Rose Above Previous Day's High | about 8 hours ago |
| 20 DMA Resistance | about 8 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/13/2024
PepGen, Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Deliver Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates that target the root cause of serious diseases.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Molecular Biology Cell Biology Peptides Oligonucleotide Nucleic Acids
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Molecular Biology Cell Biology Peptides Oligonucleotide Nucleic Acids
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.72 |
| 52 Week Low | 3.725 |
| Average Volume | 102,614 |
| 200-Day Moving Average | 10.26 |
| 50-Day Moving Average | 14.98 |
| 20-Day Moving Average | 17.11 |
| 10-Day Moving Average | 16.95 |
| Average True Range | 1.26 |
| RSI (14) | 58.85 |
| ADX | 24.08 |
| +DI | 22.57 |
| -DI | 15.82 |
| Chandelier Exit (Long, 3 ATRs) | 14.93 |
| Chandelier Exit (Short, 3 ATRs) | 18.80 |
| Upper Bollinger Bands | 18.45 |
| Lower Bollinger Band | 15.78 |
| Percent B (%b) | 0.8 |
| BandWidth | 15.60 |
| MACD Line | 0.50 |
| MACD Signal Line | 0.66 |
| MACD Histogram | -0.1594 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 21.34 | ||||
| Resistance 3 (R3) | 21.01 | 19.55 | 20.77 | ||
| Resistance 2 (R2) | 19.55 | 18.67 | 19.71 | 20.58 | |
| Resistance 1 (R1) | 18.73 | 18.13 | 19.14 | 19.05 | 20.39 |
| Pivot Point | 17.26 | 17.26 | 17.47 | 17.42 | 17.26 |
| Support 1 (S1) | 16.44 | 16.39 | 16.85 | 16.77 | 15.43 |
| Support 2 (S2) | 14.98 | 15.85 | 15.14 | 15.24 | |
| Support 3 (S3) | 14.16 | 14.98 | 15.05 | ||
| Support 4 (S4) | 14.48 |
